Munafa Stock Market Course + Intraday & FNO calls 
Array Biopharma (ARRY) Technical (Analysis) Reports Array Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Array Biopharma (ARRY)
Technical Analysis Report for USA stock ARRY Array Biopharma. Dated: 30 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock ARRY Array Biopharma then click here. or read Experts views on Array Biopharma or Forecast & share price targets of Array Biopharma
Array Biopharma Opened at 3.50 and Closed at: 3.40, which is -4.71% of previous session's close. It moved within a range of 3.29 and 3.50
The session was a Bearish session with an average volume of 2933160, which is -167.03% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
Support for tomorrow is 3.24 and resistance for tomorrow is 3.45
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 3.29, 3.19 resistance for tomorrow's hourly charts is 3.5, 3.61
10 Day SMA for Array Biopharma (ARRY) is 3.36 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Array Biopharma (ARRY) is 3.52 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Array Biopharma (ARRY) is 4 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 5.12 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Array Biopharma is 6.91 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Array Biopharma is at 3.52 and 200 DMA is at 6.91, while 50 DMA and 100 DMA are at 4 and 5.12 respectively
Array Biopharma (ARRY) moving average of 20 SMA is at 3.52 and 20 EMA is at 3.54
| Date | Closing Price | 20 SMA | 20 EMA |
| 30 Fri Oct | 3.40 | 3.52 | 3.54 |
| 29 Thu Oct | 3.56 | 3.55 | 3.56 |
| 28 Wed Oct | 3.56 | 3.57 | 3.56 |
| 27 Tue Oct | 3.39 | 3.59 | 3.56 |
| 26 Mon Oct | 3.16 | 3.62 | 3.58 |
| 23 Fri Oct | 3.19 | 3.66 | 3.62 |
Array Biopharma (ARRY) moving average of 50 SMA is at 4 and 50 EMA is at 4.06
| Date | Closing Price | 50 SMA | 50 EMA |
| 30 Fri Oct | 3.40 | 4 | 4.06 |
| 29 Thu Oct | 3.56 | 4.03 | 4.09 |
| 28 Wed Oct | 3.56 | 4.05 | 4.11 |
| 27 Tue Oct | 3.39 | 4.08 | 4.13 |
| 26 Mon Oct | 3.16 | 4.11 | 4.16 |
| 23 Fri Oct | 3.19 | 4.15 | 4.2 |
Array Biopharma (ARRY) moving average of 100 SMA is at 5.12 and 100 EMA is at 4.94
| Date | Closing Price | 100 SMA | 100 EMA |
| 30 Fri Oct | 3.40 | 5.12 | 4.94 |
| 29 Thu Oct | 3.56 | 5.15 | 4.97 |
| 28 Wed Oct | 3.56 | 5.19 | 5 |
| 27 Tue Oct | 3.39 | 5.23 | 5.03 |
| 26 Mon Oct | 3.16 | 5.28 | 5.06 |
| 23 Fri Oct | 3.19 | 5.34 | 5.1 |
Array Biopharma (ARRY) moving average of 200 SMA is at 6.91 and 200 EMA is at 5.93
| Date | Closing Price | 200 SMA | 200 EMA |
| 30 Fri Oct | 3.40 | 6.91 | 5.93 |
| 29 Thu Oct | 3.56 | 6.94 | 5.96 |
| 28 Wed Oct | 3.56 | 6.97 | 5.98 |
| 27 Tue Oct | 3.39 | 7 | 6 |
| 26 Mon Oct | 3.16 | 7.03 | 6.03 |
| 23 Fri Oct | 3.19 | 7.06 | 6.06 |
Array Biopharma has performed better than Arcus Biosciences in short term. Holding Array Biopharma could be a better choice for now!
Molina Healthcare has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Molina Healthcare, about 18.57% more returns!
Cvs Health has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Cvs Health, about 16.78% more returns!
Centene Corporation has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Centene Corporation, about 19.51% more returns!
Vertex Pharmaceuticals has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Vertex Pharmaceuticals, about 24.04% more returns!
Array Biopharma has performed better than Tiziana Life in short term. Holding Array Biopharma could be a better choice for now!
Savara Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Savara Inc, about 13.88% more returns!
Siga Technologies has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Siga Technologies, about 0.11% more returns!
Quidel Corporation has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Quidel Corporation, about 22.18% more returns!
Array Biopharma has performed better than Proqr Therapeutics in short term. Holding Array Biopharma could be a better choice for now!
Array Biopharma has performed better than Outlook Therapeutics in short term. Holding Array Biopharma could be a better choice for now!
Array Biopharma has performed better than Neurotrope Inc in short term. Holding Array Biopharma could be a better choice for now!
Array Biopharma has performed better than Minerva Neurosciences in short term. Holding Array Biopharma could be a better choice for now!
Nature S has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Nature S, about 11.83% more returns!
Iradimed Corporation has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Iradimed Corporation, about 1.72% more returns!
Evolus Inc has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Evolus Inc, about 11.3% more returns!
Array Biopharma has performed better than Cellectar Biosciences in short term. Holding Array Biopharma could be a better choice for now!
Aytu Bioscience has performed better than Array Biopharma in short term. You could have earned much better returns by investing in Aytu Bioscience, about 7.65% more returns!
Array Biopharma Technical analysis of indicators
Price action analysis of Array Biopharma (ARRY) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Array Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Array Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Array Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Array Biopharma in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Array Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.37 and Array Biopharma ARRY stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Array Biopharma ARRY stock. Volume based technical analysis of Array Biopharma ARRY stock is negative.
Array Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock ARRY Array Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ARRY Experts View which covers a lot of information including buying and selling signals
ARRY future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Array Biopharma or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Array Biopharma (ARRY) Technical (Analysis) Reports Array Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
